UB Spin-Off POP Biotechnologies Reports 100% Protection in Preclinical Trials of H5N1 Avian Flu Vaccine

As H5N1 avian influenza continues its spread across species and continents, a vaccine being developed by University of Buffalo (SUNY) spin-off&nb...

April 22, 2025 | Tuesday | News
Henlius Hosts World R&D Day 2025, Showcasing Innovation and Global Collaboration Under "Collaborate to Create" Theme

 Henlius  celebrated its World R&D Day 2025, under the theme "Collaborate to Create", bringing together senior executives, experts and indust...

April 21, 2025 | Monday | News
Akeso Secures NMPA Approval for Ebdarokimab to Treat Moderate-to-Severe Plaque Psoriasis in Adults

Akeso, Inc. is pleased to announce that ebdarokimab, an investigational monoclonal antibody developed by the company, has received marketing approval from ...

April 21, 2025 | Monday | News
CSL Behring Launches ANDEMBRY in Japan for Hereditary Angioedema Prevention

CSL Behring K.K.  President and Representative Director: Izumi Yoshida)  announced that it launched ANDEMBRY® Subcutaneous Injection 200 mg P...

April 21, 2025 | Monday | News
FDA Rejects Regeneron’s Bid for Extended Dosing of EYLEA HD® Beyond 16 Weeks

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding ...

April 21, 2025 | Monday | News
POP Biotechnologies' Nanoparticle Vaccine Shows 100% Protection Against H5N1 Avian Influenza in Preclinical Trials

As H5N1 avian influenza continues its spread across species and continents, a vaccine being developed by University of Buffalo (SUNY) spin-off&nb...

April 18, 2025 | Friday | News
GSK Welcomes ACIP Vote to Recommend Arexvy for At-Risk Adults Aged 50–59

GSK plc is pleased that the Advisory Committee on Immunization Practices (ACIP) voted in favour of recommending the use of RSV vaccines including GSK&rsquo...

April 17, 2025 | Thursday | News
Pfizer Applauds CDC Panel’s Expanded Recommendation for RSV Vaccination in At-Risk Adults Aged 50–59

Pfizer Inc. announced  that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) vote...

April 17, 2025 | Thursday | News
Celltrion’s YUFLYMA® Granted FDA Interchangeable Biosimilar Status to Humira®

Celltrion, Inc. announced that the U.S. Food and Drug Administration (FDA) has designated YUFLYMA® (adalimumab-aaty), as an interchangeable biosim...

April 15, 2025 | Tuesday | News
FDA Clears argenx SE’s VYVGART Hytrulo Prefilled Syringe for Patient Self-Injection

argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that the U.S. Food a...

April 11, 2025 | Friday | News
New Study Links SARS-CoV-2 Spike Protein Region to Autoantibody Production Potentially Driving Long COVID

 Long COVID or post COVID-19 syndrome, is a clinical entity observed in certain patients wherein symptoms of illness persist for at least several week...

April 10, 2025 | Thursday | News
South Korea Makes History with World’s First Recombinant Anthrax Vaccine Approval

GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly develop...

April 09, 2025 | Wednesday | News
ABL Bio and GSK Forge Licensing Agreement to Develop Innovative Neurodegenerative Disease Treatments Using BBB Shuttle Platform

ABL Bio Inc. a clinical-stage biotech company developing bispecific antibody technology for immuno-oncology and neurodegenerative diseases, announced a wor...

April 07, 2025 | Monday | News
India’s Gennova Biopharmaceuticals Partners with CEPI to Advance AI-Enhanced Self-Amplifying mRNA Vaccines

Gennova Biopharmaceuticals Ltd., a pioneering company in mRNA technology and vaccine development, is proud to announce a strategic partnership with the C...

April 01, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close